EGFR and non-small cell lung carcinoma: Several studies have been able to identify specific radiomics signatures that differentiate NSCLC from other benign and pre-invasive lesions, including the prediction of EGFR status and response to treatment with TKI [116,117,118,119,120,121,122,123], as well as histological subtype.